Physician profile

John A Andriulli

Cardiovascular Disease · Camden, NJ

NPI 1225063324

$110,801.29

in general payments reported to CMS, 2019-2025

30 companies · $43K in 2025

The $43K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$47,293.50
Travel and Lodging$11,608.58
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$8,086.00
Food and Beverage$5,264.26

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Philips North America LLC $79,421.41 2019-2025 Igt Devices Undivided, (9520) Igt Devices Undivided, Igt Devices Systems Undivided
Biosense Webster, INC. $14,201.63 2020-2025 Carto 3, Qdot Micro, Nuvision Ice Catheter
Cook Incorporated $3,560.00 2021
Medtronic Vascular, INC. $3,411.11 2019
Medtronic, INC. $3,280.60 2021-2025 Evera Mri Xt Dr Surescan, Micra, Aurora Ev-Icd Mri Surescan
Medical Device Business Services, INC. $3,260.77 2020-2022
Atricure, INC. $855.86 2019-2025 Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax
Janssen Pharmaceuticals, INC $694.98 2019-2024 Xarelto
Ethicon US, LLC $662.21 2020-2024 Echelon Circular, Surgicel Nu-Knit, Evarrest
Boston Scientific Corporation $200.42 2022-2025 Bodyguardian, Watchman Access System, Cds - Mct/Cem Monitoring
Stryker Corporation $165.17 2025 Artix Mt, Flowtriever, Ct Thrombectomy System Kit
Abbott Laboratories $153.62 2022-2024 Xience Skypoint
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $149.65 2019-2022
Novartis Pharmaceuticals Corporation $135.92 2019-2023
Bard Access Systems, INC. $126.62 2019
Show all 30 companies
CompanyGeneral paymentsYearsTop products
Cook Medical LLC $95.80 2019
Pfizer INC. $60.58 2019-2021
E.R. Squibb & Sons, L.L.C. $54.01 2022-2025 Eliquis
Amgen INC. $51.51 2019-2025 Repatha
Inspire Medical Systems, INC. $32.23 2024-2025 Inspire
Abiomed $29.24 2021
Inari Medical, INC. $28.90 2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Impulse Dynamics (USA) INC. $28.33 2023 Optimizer
Cvrx, INC. $28.02 2023 Barostim Neo System
Vital Connect, INC $24.69 2025 Vitalpatch Rtm
Angiodynamics, INC. $21.87 2019
Medicomp INC $20.22 2025 Telepatch Cardiac Monitor
Altathera Pharmaceuticals LLC $17.20 2024 Sotalol Hydrochloride
Mirum Pharmaceuticals, INC. $14.70 2025 Cholbam
Kiniksa Pharmaceuticals, LTD. $14.02 2023 Arcalyst

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John A Andriulli

$110,801.29

in general payments reported 2019-2025

Years
2019-2025
Top company
Philips North America LLC
Context
The $43K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/146389/john-a-andriulli

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.